AIMOVIG vs COMBIPRES

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 12, 2026·How we rate

Possible drug interaction. AIMOVIG and COMBIPRES are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AIMOVIG	COMBIPRES
Rating	72/100	72/100
Pharmacy pays	—	~$2.67 /30
Type	RX	RX
Active ingredient	ERENUMAB-AOOE	CHLORTHALIDONE AND CLONIDINE HYDROCHLORIDE
Manufacturer	Amgen Inc	Boehringer Ingelheim
Dosage forms	Injectable, Solution	Tablet
Drug class	—	—
Boxed warning	None	None
Half-life	—	about 40 hours on average (the label reports a mean half-life of 40 hours after a 50–200 mg dose, and an elimination half-life of 53 hours after 50 mg and 60 hours after 100 mg)

aimovig combipres

Rating

72/100

Pharmacy pays

—

~$2.67 /30

Type

Active ingredient

ERENUMAB-AOOE

CHLORTHALIDONE AND CLONIDINE HYDROCHLORIDE

Manufacturer

Amgen Inc

Boehringer Ingelheim

Dosage forms

Injectable, Solution

Tablet

Drug class

—

Boxed warning

None

Half-life

—

about 40 hours on average (the label reports a mean half-life of 40 hours after a 50–200 mg dose, and an elimination half-life of 53 hours after 50 mg and 60 hours after 100 mg)

Frequently asked questions

Which is better-rated, Aimovig or Combipres?

Aimovig and Combipres are tied at 3.6 out of 5 by our independent rating.

What is the difference between Aimovig and Combipres?

Aimovig contains Erenumab-Aooe, while Combipres contains Chlorthalidone and Clonidine Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.